GlassScriptPhysician profile
Marco Yung
NPI 1578856647
$4,573.59
in general payments reported to CMS, 2019-2025
11 companies · $1,136 in 2025
The $1,136 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.05 · 2020: $232 · 2021: $611 · 2022: $1,904 · 2023: $412 · 2024: $263 · 2025: $1,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $810.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,750.24 | 2022-2025 | Da Vinci Surgical System |
| Zimmer Biomet Holdings, INC. | $579.75 | 2021-2023 | Advantagerib |
| Ethicon US, LLC | $419.20 | 2020-2022 | |
| Davol INC. | $318.06 | 2023-2024 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $184.28 | 2024 | |
| Allergan, INC. | $114.38 | 2022 | |
| Atricure, INC. | $111.14 | 2020 | |
| Acell, INC. | $38.96 | 2020 | |
| Smith+Nephew, INC. | $24.93 | 2022 | |
| Prytime Medical Devices, INC. | $16.60 | 2024 | Er-Reboa Plus |
| W. L. Gore & Associates, INC. | $16.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Yung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.